Ror2: A Novel Regulator Of Cardiomyocyte Structure And Target Of Right Ventricular Failure

被引：0
|
作者：
Edwards, Jonathan J.
Uchida, Keita
Shewale, Swapnil V.
Yucel, Nora
Scarborough, Emily A.
Yang, Yifan
Li, Li
Prosser, Benjamin
Arany, Zoltan
机构：
来源：
CIRCULATION RESEARCH | 2021年 / 129卷
关键词：
D O I：
10.1161/res.129.suppl_1.P322
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P322
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ROR2: A NOVEL REGULATOR OF CARDIOMYOCYTE PROLIFERATION AND PROTEIN QUALITY CONTROL
    Edwards, Jonathan
    Uchida, Keita
    Yucel, Nora
    Scarborough, Emily
    Brandimarto, Jeff
    Yang, Yifan
    Li, Li
    Williams, Spencer
    Prossser, Benjamin
    Arany, Zolt
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 321 - 321
  • [2] ROR2 Drives Right Ventricular Failure Via Proteostatic Imbalances
    Edwards, Jonathan
    Uy, Genevieve
    Hartman, Hali
    Uchida, Keita
    Scarborough, Emily
    Yang, Yifan
    Barr, Eric
    Brandimarto, Jeff
    Li, Li
    Eaton, Deborah
    Conn, Crystal
    Bedi, Kenneth
    Margulies, Kenneth
    Prosser, Benjamin
    Arany, Zoltan
    CIRCULATION RESEARCH, 2024, 135
  • [3] Ror2: A novel regulator of osteoblast differentiation.
    Billiard, J
    Liu, Y
    Bhat, RA
    Mangine, A
    Moran, RA
    Seestaller-Wehr, LM
    Bodine, PVN
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S358 - S358
  • [4] Ror2 as a Therapeutic Target in Cancer
    Debebe, Zufan
    Rathmell, W. Kimryn
    PHARMACOLOGY & THERAPEUTICS, 2015, 150 : 143 - 148
  • [5] ROR2 is a novel target for CAR T cells in breast cancer
    Nerreter, T.
    Peng, H.
    Rader, C.
    Grawunder, U.
    Einsele, H.
    Hudecek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 130 - 130
  • [6] Ror2-mediated Proteostatic Disruption As A Novel Mechanism For Right Ventricular Failure
    Edwards, Jonathan J.
    Uy, Gen
    Uchida, Keita
    Scarborough, Emily
    Yang, Yifan
    Brandimarto, Jeff
    Li, Li
    Yucel, Nora
    Prosser, Benjamin
    Arany, Zoltan
    CIRCULATION RESEARCH, 2023, 133
  • [7] Ror2, a Novel Key Regulator Driving Cell Fate Decisions throughout Pancreatic Carcinogenesis
    Benitz, Simone
    Steep, Alec
    Nasser, Malak
    Preall, Jonathan
    Mahajan, Ujjwal Mukund
    McQuithey, Holly
    Loveless, Ian
    Davis, Erick T.
    Wen, Hui-Ju
    Long, Daniel W.
    Metzler, Thomas
    Zwernik, Samuel
    Louw, Michaela
    Rempinski, Donald
    Salas-Escabillas, Daniel
    Brender, Sydney
    Song, Linghao
    Huang, Ling
    Theisen, Brian K.
    Zhang, Zhenyu
    Steele, Nina G.
    Regel, Ivonne
    Bednar, Filip
    Crawford, Howard C.
    CANCER RESEARCH, 2024, 84 (17)
  • [8] ROR2 IS A NOVEL TARGET OF THE WNT SIGNALING PATHWAY INVOLVED IN METASTASIS AND CHEMOTHERAPY RESISTANCE
    Henry, C. E.
    Knipprath-Meszaros, A. M.
    Llamosas, E.
    Schotzau, A.
    Obermann, E.
    Fink, D.
    Hacker, N.
    Ward, R. L.
    Heinzelmann-Schwarz, V.
    Ford, C. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 476 - 476
  • [9] ROR2: A Potential Therapeutic Target in Soft Tissue Tumors
    Edris, B.
    Espinosa, I.
    Beck, A. H.
    Lee, C-H
    Lazar, A. J.
    Lev, D.
    Fletcher, J. A.
    West, R. B.
    Nusse, R.
    van de Rijn, M.
    MODERN PATHOLOGY, 2011, 24 : 13A - 13A
  • [10] ROR2: A Potential Therapeutic Target in Soft Tissue Tumors
    Edris, B.
    Espinosa, I.
    Beck, A. H.
    Lee, C-H
    Lazar, A. J.
    Lev, D.
    Fletcher, J. A.
    West, R. B.
    Nusse, R.
    van de Rijn, M.
    LABORATORY INVESTIGATION, 2011, 91 : 13A - 13A
12345